Cart
sales@molnova.com
p-O-Farnesylcoumaric acid
CAS No. 939769-47-8
p-O-Farnesylcoumaric acid( ——— )
Catalog No. M39386 CAS No. 939769-47-8
p-O-Farnesylcoumaric acid
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namep-O-Farnesylcoumaric acid
-
NoteResearch use only, not for human use.
-
Brief Descriptionp-O-Farnesylcoumaric acid
-
Descriptionp-O-Farnesylcoumaric acid
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number939769-47-8
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BI-1935
BI-1935 is an inhibitor of soluble epoxide hydrolase (sEH).
-
Resinacein L
Resinacein L is an inhibitor for α-glucosidase with an IC50 of 0.635 mM. Resinacein L slows down the digestion and absorption of carbohydrates, thereby decreasing postprandial blood glucose.
-
Litifilimab
Litifilimab, a humanized IgG1-κ antibody, targets the C-type lectin domain family 4 member C (CLEC4C) and has potential applications in the study of cutaneous lupus erythematosus (CLE) .
